The antitumor drug Ribomustin is used for chronic lymphocytic leukemia.
The antineoplastic effect of bendamustine has been confirmed in numerous in vitro studies on various tumor cell lines (breast cancer, non-small cell and small cell lung cancer, ovarian cancer and various types of leukemia, as well as colon cancer, melanoma, renal cell carcinoma, prostate malignancies and brain) and in vivo – on various experimental tumor models (melanoma, breast cancer, sarcoma, lymphoma, leukemia and small cell lung cancer)
Active ingredient: bendamustine
Prescription medicine.
Дозировка | 25 Mg 4 vial, 100 Mg 4 vial |
---|